NEW YORK, May 4, 2016 /PRNewswire/ -- This market research
study analyzes the biochips market on global basis and provides
estimates in terms of revenue (USD million) from 2014 to 2023. It
describes the market dynamics affecting the industry and analyzes
their impact through the forecast period. Moreover, it highlights
the significant opportunities for market growth in the next eight
years.
Biochips are a collection of microarrays which are arranged on a
solid substrate that enables numerous biochemical reactions such as
decoding of genes in a few seconds. In addition, biochips are
designed to function in biological environments and are capable of
detecting and measuring a large number of biomarkers and perform
complex biochemical reactions simultaneously in a very short span
of time. There have been considerable advancements in the
biotechnology industry on account of the increasing application of
biochips. In addition, biochips are largely used for research in
drug discovery and development, genomics, proteomics, and molecular
diagnostics. Biochips help in analyzing organic molecules related
to living organisms. Therefore, they help in detecting gene
sequences, environmental pollutants, airborne toxins, and other
biochemical constituents.
Increasing application of biochips in the medical sector for cancer
treatment, drug research, and diagnostics is one of the major
factors driving the growth of the global biochips market. In
addition, factors such as availability of molecular information,
automation of biochemical processes through the use of biochips and
application of biochips for gene and protein identification are set
to drive the global biochips market.
The use of biochips has brought about a transition in the field of
drug discovery and research. Biochips have the ability to detect
cancer before its symptoms develop in human bodies. In addition, it
can easily detect virulent diseases such as smallpox, anthrax, and
plague in a very short span of time. Moreover, biochips are
increasingly finding application in veterinary diagnostics.
Biochips comprise grids that may be dots or small wells. Each grid
contains nucleic acid or antibodies and proteins which bind to a
DNA sequence or a target antigen. The abundance of proteomics and
genetics data coupled with the need for identifying gene sequences
and proteins in human beings is driving the biochips market.
Conventional gene and protein sequencing methods cannot provide
qualitative output and are ineffective whereas biochips are
extremely effective and produce accurate gene sequencing results in
a very short span of time.
Significant growth in the healthcare sector, rising demands for
diagnostics and increasing medical expenditure coupled with
economic reforms in major developing countries has been able to
bolster the growth of this market. Asia
Pacific and Rest of the World (RoW) are key markets for the
future and are expected to provide huge opportunities to the global
biochips manufacturers.
The market is segmented on the basis of geography into Europe, North
America, Asia Pacific and
Rest of the World (RoW). These segments have been estimated in
terms of revenue (USD million). In addition, the report has been
segmented based on types, which includes DNA chips, protein chips
and microfluidic devices. In addition, the report is also segmented
by application that includes drug discovery & development,
genomics, proteomics and in vitro diagnostics.
For better understanding of the biochips market, the study
comprises market attractiveness analysis, where the types of
biochips are benchmarked based on their market scope, growth rate
and market attractiveness.
The report also provides company market share analysis of the
various industry participants. Key players have been profiled and
their company overview, financial overview, business strategies and
recent developments have been covered in the report. Major market
participants profiled in this report include Affymetrix Inc.,
Illumina Inc., GE Healthcare Ltd., Agilent Technologies Inc.,
Fluidigm Corporation and Cepheid Inc. among others.
The biochips market has been segmented as:
Global Biochips Market: By Type
DNA Chips
Protein Chips
Microfluidic Devices
Global Biochips Market: By Application
Drug Discovery & Development
Genomics
Proteomics
In Vitro Diagnostics
Global Biochips Market: By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
Italy
France
Germany
Rest of Europe
Asia Pacific
China
India
Japan
Rest of Asia Pacific
Rest of the World (RoW)
Latin America
U.A.E.
South Africa
Others
The report provides a cross-sectional analysis of by type and of by
application segment with respect to the above mentioned
regions.
Read the full report:
http://www.reportlinker.com/p03812924-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biochips-market---global-industry-analysis-size-share-growth-trends-and-forecast-2015---2023-300263262.html
SOURCE Reportlinker